274 related articles for article (PubMed ID: 36902304)
1. Integrated Bioinformatics Analysis of Shared Genes, miRNA, Biological Pathways and Their Potential Role as Therapeutic Targets in Huntington's Disease Stages.
Christodoulou CC; Papanicolaou EZ
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902304
[TBL] [Abstract][Full Text] [Related]
2. Investigating the Transition of Pre-Symptomatic to Symptomatic Huntington's Disease Status Based on Omics Data.
Christodoulou CC; Zachariou M; Tomazou M; Karatzas E; Demetriou CA; Zamba-Papanicolaou E; Spyrou GM
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33049985
[TBL] [Abstract][Full Text] [Related]
3. miR-10b-5p expression in Huntington's disease brain relates to age of onset and the extent of striatal involvement.
Hoss AG; Labadorf A; Latourelle JC; Kartha VK; Hadzi TC; Gusella JF; MacDonald ME; Chen JF; Akbarian S; Weng Z; Vonsattel JP; Myers RH
BMC Med Genomics; 2015 Mar; 8():10. PubMed ID: 25889241
[TBL] [Abstract][Full Text] [Related]
4. Identification of differentially expressed genes and regulatory relationships in Huntington's disease by bioinformatics analysis.
Dong X; Cong S
Mol Med Rep; 2018 Mar; 17(3):4317-4326. PubMed ID: 29328442
[TBL] [Abstract][Full Text] [Related]
5. Bioinformatic gene analysis for potential therapeutic targets of Huntington's disease in pre-symptomatic and symptomatic stage.
Xiang C; Cong S; Liang B; Cong S
J Transl Med; 2020 Oct; 18(1):388. PubMed ID: 33054835
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatic analysis of a microRNA regulatory network in Huntington's disease.
Wang ZM; Dong XY; Cong SY
J Integr Neurosci; 2020 Dec; 19(4):641-650. PubMed ID: 33378838
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs located in the Hox gene clusters are implicated in huntington's disease pathogenesis.
Hoss AG; Kartha VK; Dong X; Latourelle JC; Dumitriu A; Hadzi TC; Macdonald ME; Gusella JF; Akbarian S; Chen JF; Weng Z; Myers RH
PLoS Genet; 2014 Feb; 10(2):e1004188. PubMed ID: 24586208
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatic analysis of microRNA expression in Huntington's disease.
Dong X; Cong S
Mol Med Rep; 2018 Sep; 18(3):2857-2865. PubMed ID: 30015953
[TBL] [Abstract][Full Text] [Related]
9. Human microRNA-4433 (hsa-miR-4443) Targets 18 Genes to be a Risk Factor of Neurodegenerative Diseases.
Ge X; Yao T; Zhang C; Wang Q; Wang X; Xu LC
Curr Alzheimer Res; 2022; 19(7):511-522. PubMed ID: 35929619
[TBL] [Abstract][Full Text] [Related]
10. miR-34a-5p as molecular hub of pathomechanisms in Huntington's disease.
Hart M; Diener C; Lunkes L; Rheinheimer S; Krammes L; Keller A; Meese E
Mol Med; 2023 Apr; 29(1):43. PubMed ID: 37013480
[TBL] [Abstract][Full Text] [Related]
11. Key Genes Associated with Pyroptosis in Gout and Construction of a miRNA-mRNA Regulatory Network.
Bai B; Liu Y; Abudukerimu A; Tian T; Liang M; Li R; Sun Y
Cells; 2022 Oct; 11(20):. PubMed ID: 36291136
[TBL] [Abstract][Full Text] [Related]
12. Shared miRNA landscapes of COVID-19 and neurodegeneration confirm neuroinflammation as an important overlapping feature.
Redenšek Trampuž S; Vogrinc D; Goričar K; Dolžan V
Front Mol Neurosci; 2023; 16():1123955. PubMed ID: 37008787
[TBL] [Abstract][Full Text] [Related]
13. High-Throughput Sequencing of BACHD Mice Reveals Upregulation of Neuroprotective miRNAs at the Pre-Symptomatic Stage of Huntington's Disease.
Olmo IG; Olmo RP; Gonçalves ANA; Pires RGW; Marques JT; Ribeiro FM
ASN Neuro; 2021; 13():17590914211009857. PubMed ID: 33906482
[TBL] [Abstract][Full Text] [Related]
14. Identification of Potential miRNA-mRNA Regulatory Network Contributing to Parkinson's Disease.
Yin X; Wang M; Wang W; Chen T; Song G; Niu Y; Jiang Z; Gao Z; Wang Z
Parkinsons Dis; 2022; 2022():2877728. PubMed ID: 36105301
[TBL] [Abstract][Full Text] [Related]
15. Three hematologic/immune system-specific expressed genes are considered as the potential biomarkers for the diagnosis of early rheumatoid arthritis through bioinformatics analysis.
Cheng Q; Chen X; Wu H; Du Y
J Transl Med; 2021 Jan; 19(1):18. PubMed ID: 33407587
[TBL] [Abstract][Full Text] [Related]
16. Circulating microRNAs in Huntington's disease: Emerging mediators in metabolic impairment.
Díez-Planelles C; Sánchez-Lozano P; Crespo MC; Gil-Zamorano J; Ribacoba R; González N; Suárez E; Martínez-Descals A; Martínez-Camblor P; Álvarez V; Martín-Hernández R; Huerta-Ruíz I; González-García I; Cosgaya JM; Visioli F; Dávalos A; Iglesias-Gutiérrez E; Tomás-Zapico C
Pharmacol Res; 2016 Jun; 108():102-110. PubMed ID: 27155059
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of miR-9* in the peripheral leukocytes of Huntington's disease patients.
Chang KH; Wu YR; Chen CM
Orphanet J Rare Dis; 2017 Dec; 12(1):185. PubMed ID: 29258536
[TBL] [Abstract][Full Text] [Related]
18. Network pharmacology-based identification of miRNA expression of Astragalus membranaceus in the treatment of diabetic nephropathy.
Dai Y; Guo M; Jiang L; Gao J
Medicine (Baltimore); 2022 Feb; 101(5):e28747. PubMed ID: 35119030
[TBL] [Abstract][Full Text] [Related]
19. Bioinformatics analysis of miRNA and mRNA expression profiles to reveal the key miRNAs and genes in osteoarthritis.
Huang PY; Wu JG; Gu J; Zhang TQ; Li LF; Wang SQ; Wang M
J Orthop Surg Res; 2021 Jan; 16(1):63. PubMed ID: 33468167
[TBL] [Abstract][Full Text] [Related]
20. Identification of the key genes and microRNAs in adult acute myeloid leukemia with FLT3 mutation by bioinformatics analysis.
Chen S; Chen Y; Zhu Z; Tan H; Lu J; Qin P; Xu L
Int J Med Sci; 2020; 17(9):1269-1280. PubMed ID: 32547322
[No Abstract] [Full Text] [Related]
[Next] [New Search]
